Psychiatry and Neurology, Neurology · Paoli, PA
NPI
1588942643
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
250 W Lancaster Ave Ste 260
Paoli, PA, 19301
Phone (484) 413-2572
Groups this clinician bills Medicare through
Medicare paid, 2024
$761K
58,258 services
Medicare patients, 2024
321
Average age 71
Drug cost, 2024
$6.3M
2,346 prescriptions
Company payments, 2025
$1,555
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sudhir Aggarwal was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 2,492 times for 37 patients. In total Sudhir Aggarwal billed 58,258 services in 57 codes, and Medicare paid $761K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,492 | 37 | $0.07 | $168 |
| 96375 Injection Administration | Office | 2,188 | 43 | $11.47 | $25K |
| 96366 Intravenous Infusion, Hydration | Office | 1,324 | 39 | $15.05 | $20K |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 1,284 | 32 | $0.10 | $123 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 893 | 35 | $0.49 | $441 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 766 | 18 | $0.43 | $332 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 583 | 41 | $0.59 | $344 |
| 96365 Intravenous Infusion, Hydration | Office | 532 | 40 | $47.40 | $25K |
| 99215 Office E&M - Established | Office | 447 | 235 | $132.61 | $59K |
| 93041 Electrocardiogram | Office | 445 | 34 | $4.74 | $2,108 |
| 99497 Care Management/Coordination | Office | 283 | 283 | $65.32 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 240 | 165 | $12.61 | $3,027 |
| 96367 Intravenous Infusion, Hydration | Office | 147 | 22 | $20.94 | $3,078 |
| 99205 Office E&M - New | Office | 119 | 119 | $172.38 | $21K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 81 | 37 | $24.38 | $1,975 |
By year: 2022 $256K for 10,204 services; 2023 $568K for 29,399 services; 2024 $761K for 58,258 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sudhir Aggarwal prescribed most often to Medicare patients was Gabapentin, with 175 prescriptions and refills. In total Sudhir Aggarwal wrote 2,346 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 175 | 447 | 54 | $2,647 |
| Donepezil Hcl Generic | 161 | 366 | 56 | $1,915 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 113 | 267 | 31 | $4,820 |
| Tizanidine Hcl Generic | 104 | 235 | 34 | $1,991 |
| Pregabalin Generic | 91 | 239 | 30 | $2,446 |
| Meloxicam Generic | 80 | 96 | 28 | $289 |
| Memantine Hcl Generic | 78 | 153 | 17 | $1,752 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 73 | 73 | Under 11 | $1.6M |
| Duloxetine Hcl Generic | 69 | 137 | 23 | $1,442 |
| Escitalopram Oxalate Generic | 68 | 156 | 21 | $954 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 61 | 61 | Under 11 | $712K |
| Primidone Generic | 55 | 134 | 20 | $1,378 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 54 | 54 | Under 11 | $708K |
| Sodium Chloride 0.9 % Sodium Chloride | 53 | 53 | Under 11 | $822 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 53 | 53 | Under 11 | $1.0M |
Brand drugs: - claims; generic drugs: 1,786 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sudhir Aggarwal $1,555 ($1,555 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $264.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $264 |
| Biogen, Inc. BIIB | 7 | $254 |
| Pfizer Inc. PFE | 21 | $248 |
| Argenx US, Inc. ARGX | 7 | $157 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $75.66 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $55.44 |
| Merz Pharmaceuticals, LLC | 3 | $53.87 |
| Axsome Therapeutics, Inc. AXSM | 2 | $42.47 |
| Lundbeck LLC | 2 | $39.32 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $33.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.